These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6151669

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors.
    Gergen KA, Zadina JE, Kastin AJ, Paul D.
    Eur J Pharmacol; 1996 Mar 18; 298(3):235-9. PubMed ID: 8846821
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum.
    Zadina JE, Kastin AJ, Kersh D, Wyatt A.
    Life Sci; 1992 Mar 18; 51(11):869-85. PubMed ID: 1355851
    [Abstract] [Full Text] [Related]

  • 9. Tyr-MIF-1, identified in brain tissue, and its analogs are active in two models of antinociception.
    Kastin AJ, Stephens E, Zadina JE, Coy DH, Fischman AJ.
    Pharmacol Biochem Behav; 1985 Dec 18; 23(6):1045-9. PubMed ID: 2867563
    [Abstract] [Full Text] [Related]

  • 10. Antiopioid properties of the TYR-MIF-1 family.
    Bocheva A, Dzambazova-Maximova E.
    Methods Find Exp Clin Pharmacol; 2004 Nov 18; 26(9):673-7. PubMed ID: 15632952
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dopamine receptor antagonists block the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia.
    Krowicki ZK.
    Neuropeptides; 1991 Aug 18; 19(4):281-5. PubMed ID: 1681456
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of neonatal treatment with Tyr-MIF-1, morphiceptin, and morphine on development, tail flick, and blood-brain barrier transport.
    Harrison LM, Zadina JE, Banks WA, Kastin AJ.
    Brain Res Dev Brain Res; 1993 Oct 15; 75(2):207-12. PubMed ID: 7903224
    [Abstract] [Full Text] [Related]

  • 15. Naloxone-like actions of MIF-1 do not require the presence of the pituitary.
    Kastin AJ, Nissen C, Zadina JE, Schally AV, Ehrensing RH.
    Pharmacol Biochem Behav; 1980 Dec 15; 13(6):907-12. PubMed ID: 6111087
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
    Watanabe H, Nakayama D, Ito K, Watanabe C, Mizoguchi H, Fujimura T, Murayama K, Kawamura S, Sato T, Sakurada C, Sakurada T, Sakurada S.
    J Pharmacol Exp Ther; 2005 Mar 15; 312(3):1075-81. PubMed ID: 15561796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.